SMALLPOX VACCINE (ACAM2000,IMVAMUNE)

Course overview

Smallpox vaccine is FDA-approved to prevent smallpox (variola) in persons ≥ 16 years who are at high risk for smallpox infection. It must be used cautiously in immunocompromised persons and persons with steroid-treated eye disease, current/history of cardiovascular disease, and current/history of eczema or other acute/chronic exfoliative skin conditions. This continuing education module is designed to give the reader/learner an increased understanding of smallpox vaccine. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.